Journal
BIOSENSORS & BIOELECTRONICS
Volume 89, Issue -, Pages 598-605Publisher
ELSEVIER ADVANCED TECHNOLOGY
DOI: 10.1016/j.bios.2016.01.077
Keywords
Graphene oxide; Single strand DNA; Vascular endothelial growth factor (VEGF); Prostate-specific antigen (PSA); Electrochemical biosensor; Prostate cancer (PCa)
Categories
Funding
- Ministry of Science and Technology
- Food Industry Research and Development Institute, Taiwan (R.O.C.) [MOST103-2320-B-110-004-MY2, CMRPG3E2041, CMRPG3B1601, GERPD2E0031]
- Chang Gung Memorial Hospital
Ask authors/readers for more resources
Early diagnosis of prostate cancer (PCa) is critical for the prevention of metastasis and for early treatment; therefore, a simple and accurate device must be developed for this purpose. In this study, we reported a novel fabrication method for producing a dual-modality biosensor that can simultaneously detect vascular endothelial growth factor (VEGF) and prostate-specific antigen (PSA) in human serum for early diagnosis of PCa. This biosensor was constructed by coating graphene oxideissDNA (GO-ssDNA) on an Au-electrode for VEGF detection, and incorporated with poly-L-lactide nanoparticles (PLLA NPs) for signal amplification and PSA detection. The results showed that this biosensor has wide liner detection ranges (0.05-100 ng/mL for VEGF and 1-100 ng/mL for PSA), as well as high levels of sensitivity and selectivity (i.e., resisting interference from external factors, such as glucose, ascorbic acid human serum protein, immunoglobulin G, and immunoglobulin M), and demonstrated a high correlation with an enzyme-linked immunosorbent assay for sample detection in patients. Therefore, this biosensor could be utilized for early clinical diagnosis of PCa in the future. (C) 2016 Elsevier B.V. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available